Infant leukaemias and cot deaths

Insights

Infant leukaemias, potentially linked to fetal origins and rapid growth, may cause sudden infant death (cot deaths). This risk is higher in boys and during the first year, especially during winter months.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Immunology

Background:

  • Infant leukaemias exhibit distinct characteristics compared to childhood leukaemias.
  • Haemopoietic neoplasms in infants may arise from fetal origins and exhibit rapid growth rates.
  • These neoplasms might interfere with the development of the reticuloendothelial system, leading to sudden infant death, including stillbirths and cot deaths.

Purpose of the Study:

  • To explore the unique aspects of infant leukaemias.
  • To investigate the potential link between infant leukaemias and sudden infant death syndrome (cot deaths).
  • To examine the influence of age, sex, and season on infant leukaemia incidence and presentation.

Main Methods:

  • Comparative analysis of infant versus childhood leukaemias.
  • Epidemiological investigation of cot death and leukaemia incidence.
  • Analysis of leukaemia subtype ratios (myeloid vs. lymphatic) in relation to age and birth season.

Main Results:

  • Infant leukaemias, characterized by fetal origins and rapid growth, are hypothesized to disrupt normal development, causing sudden infant death.
  • Cot deaths show a higher incidence in boys and peak during the first half of infancy, coinciding with the transition to active immunity.
  • Infants born between July and December face increased risk due to winter exposure between 1 to 5 months of age.
  • A shift in the myeloid to lymphatic leukaemia ratio occurs within three months of birth, with more girls and children born January-June affected during this period.

Conclusions:

  • Infant leukaemias may represent a distinct disease process with implications for sudden infant death.
  • The timing of immune system development and environmental factors (e.g., winter conditions) appear to influence the risk and presentation of infant leukaemias.
  • Seasonal and sex-based variations in leukaemia incidence and type suggest complex interactions between developmental, immunological, and environmental factors.

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...